Wuxi Pharmatech (Cayman) Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Wuxi Pharmatech (Cayman) Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2017
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:92
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Wuxi Pharmatech (Cayman) Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Wuxi Pharmatech (Cayman) Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Wuxi Pharmatech (Cayman) Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Wuxi Pharmatech (Cayman) Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Wuxi Pharmatech (Cayman) Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Wuxi Pharmatech (Cayman) Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Wuxi Pharmatech (Cayman) Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Wuxi Pharmatech (Cayman) Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Wuxi Pharmatech (Cayman) Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 21
Corporate Venturing – Overview 21
Corporate Venturing – Deal reports 22
PARTNERSHIP 26
Partnership – Overview 26
Partnership – Deal reports 27
CAPITAL RAISING 61
Capital Raising – Deal reports 61
PRIVATE EQUITY & OWNERSHIP 68
Private Equity and Ownership – Overview 68
Private Equity and Ownership – Deal reports 69
APPENDIX 82
Contact Us 82
About MarketLine Financial Deals Database 82
Deal Definition and Methodology 84
About MarketLine 91

List of Tables
Table 1: Wuxi Pharmatech M&A volume and value trend (2014-YTD2018)
Table 2: Wuxi Pharmatech M&A activity by geography (2014-YTD2018)
Table 3: Wuxi Pharmatech corporate venturing volume and value trend (2014-YTD2018)
Table 4: Wuxi Pharmatech corporate venturing by geography (2014-YTD2018)
Table 5: Wuxi Pharmatech partnership volume and value trend (2014-YTD2018)
Table 6: Wuxi Pharmatech partnership trend by key deal type (2014-YTD2018)
Table 7: Wuxi Pharmatech private equity and ownership volume and value trend (2014-YTD2018)
Table 8: Wuxi Pharmatech private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Wuxi Pharmatech M&A volume and value trend (2014-YTD2018)
Figure 2: Wuxi Pharmatech M&A activity by geography (2014-YTD2018)
Figure 3: Wuxi Pharmatech corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Wuxi Pharmatech corporate venturing by geography (2014-YTD2018)
Figure 5: Wuxi Pharmatech partnership volume and value trend (2014-YTD2018)
Figure 6: Wuxi Pharmatech partnership trend by key deal type (2014-YTD2018)
Figure 7: Wuxi Pharmatech private equity and ownership volume and value trend (2014-YTD2018)
Figure 8: Wuxi Pharmatech private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Wuxi Pharmatech (Cayman) Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kian Joo Can Factory Berhad:企業の戦略・SWOT・財務情報
    Kian Joo Can Factory Berhad - Strategy, SWOT and Corporate Finance Report Summary Kian Joo Can Factory Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Artisan Partners Asset Management Inc.:企業の戦略・SWOT・財務情報
    Artisan Partners Asset Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Artisan Partners Asset Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Vattenfall AB:企業の戦略的SWOT分析
    Vattenfall AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Fresenius Kabi AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Pharmagest Interactive SA (PHA):企業の財務・戦略的SWOT分析
    Summary Pharmagest Interactive SA (Pharmagest Interactive) is a technology company that develops and markets professional IT solutions for pharmacies and pharmaceutical industries. The company operates through four divisions such as pharmaceutical, fintech, e-health, and health and medico-social div …
  • United Services Automobile Association:企業のM&A・事業提携・投資動向
    United Services Automobile Association - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Services Automobile Association Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • NeuroPace Inc-医療機器分野:企業M&A・提携分析
    Summary NeuroPace Inc (NeuroPace) is a medical device company that designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders. The company’s products include cutting edge medical devices, RNS systems, patient data management systems, magnet products, …
  • Ciber, Inc.:企業の戦略・SWOT・財務情報
    Ciber, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ciber, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kao Corp (4452):企業の財務・戦略的SWOT分析
    Kao Corp (4452) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Myers Industries Inc (MYE):企業の財務・戦略的SWOT分析
    Summary Myers Industries Inc (Myers) is a chemical company that manufactures and distributes plastic and rubber products. The company offers plastic storage containers, rubber tire repair products, custom plastic and rubber products, tire balancers and tire retread products. It also provides materia …
  • Splendid Metal Products Limited:企業の戦略・SWOT・財務情報
    Splendid Metal Products Limited - Strategy, SWOT and Corporate Finance Report Summary Splendid Metal Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Phillips-Medisize Corp:医療機器:M&Aディール及び事業提携情報
    Summary Phillips-Medisize Corp (Phillips-Medisize) is a provider of outsourced design and manufacturing services to medical, defense, consumer, and automotive markets. The company operates as a subsidiary of Molex LLC. It offers a broad range of pre-production and production services. The company of …
  • Analog Modules, Inc.:企業の戦略・SWOT・財務情報
    Analog Modules, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Modules, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vale Canada Ltd:企業の戦略・SWOT・財務情報
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Boart Longyear Ltd:企業の戦略・SWOT・財務情報
    Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report Summary Boart Longyear Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Urenco Ltd:企業の戦略・SWOT・財務分析
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as beleodaq and asidna among others. It offers drugs for the treatment of liver cancer, and treatment and pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆